“For us, a trade is over-owned when it gets overhyped, and health care’s not overhyped right now. I even know a couple of health care PM’s who don’t know the sector’s at all-time highs right now,” he said. “I think there’s a lot more room to grow.”
Specifically, Verrone pointed out that Pfizer and Merck charts were breaking through 12-year downtrends.
“Health care gives you a hedge to what could be a tough couple of months for the broader market,” he added.
Got something to to say? Email us at email@example.com and your comment might be posted on the Rapid Recap. If you'd prefer to make a comment, but not have it published on our website, email firstname.lastname@example.org.